Expression of insulin-like growth factor-1 receptor in synovial sarcoma: Association with an aggressive phenotype

Cancer Research

Volumn 59, Issue 15, 1999, Pages 3588-3591

  Xie, Yuntao ^a   Skytting, Björn ^a,b   Nilsson, Gunnar ^a   Brodin, Bertha ^a   Larsson, Olle ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C RECEPTOR;

ARTICLE; CANCER SURVIVAL; CELL PROLIFERATION; CLINICAL ARTICLE; DIAGNOSTIC VALUE; HUMAN; HUMAN CELL; LUNG METASTASIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYNOVIAL SARCOMA;

ADULT; BLOTTING, WESTERN; BONE NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LUNG NEOPLASMS; MALE; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; ONCOGENE PROTEINS, FUSION; PHENOTYPE; RECEPTOR, IGF TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; SARCOMA, EWING'S; SARCOMA, SYNOVIAL; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0033179378     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Enzinger, F. M., and Weiss, S. W. Soft Tissue Tumors, Ed 3. St. Louis: Mosby, 1995.
2. Choong, P. F., Åkerman, M., Willen, H., Andersson, C., Gustafson, P., Alvegard, T., and Rydholm, A. Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in soft tissue sarcoma. Is prognostic significance histotype-specific? APMIS, 103: 797-805, 1995.
3. Clark, J., Rocques, P. J., Gill, S., Shipley, J., Chan, A. M., Gustrson, B. A., and Cooper, C. S. Identification of novel genes, SYT and SSX, involved in the t(X; 18)(p11.2;q11.2) translocation found in human synovial sarcoma. Nat. Genet., 7: 502-508, 1994.
4. Crew, J., Clark, J., Fisher, C., Gill, S., Grimer, R., and Mitchell, P. Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcoma. EMBO J., 14: 2333-2340, 1995.
5. Skytting, B., Nilsson, G., Brodin, B., Xie, Y., Lundeberg, J., Uhlén, M., and Larsson, O. A novel fusion gene, SYT-SSX4, in synovial sarcoma. J. Natl. Cancer Inst., 91: 974-975, 1999.
6. Nilsson, G., Skytting, B., Xie, Y., Brodin, B., Perfekt, R., Mandahl, N., Lundeberg, J., Uhlén, M., and Larsson, O. The SYT-SSX1 variant of synovial sarcoma is associated with high rate of tumor cell proliferation and poor clinical outcome. Cancer Res., 59: 3180-3184, 1999.
7. Kawai, A., Woodruff, J., Healey, J. H., Brennan, M. F., Antonescu, C. R., and Ladanyi, M. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma. N. Engl. J. Med., 338: 153-160, 1998.
8. Massague, J., and Czech, M. P. The subunit structure of two distinct receptors for insulin-like growth factors I and II and their relationship to the insulin receptor. J. Biol. Chem., 257: 538-545, 1992.
9. Baserga, R. The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res., 55: 249-252, 1995.
10. Renicoff, M., Burgaud, J-L., Rotman, H. L., Abraham, D., and Baserga, R. Correlation between apoptosis, tumorigenesis, and levels of insulin-like growth factor I receptors. Cancer Res., 55: 3739-3741, 1995.
11. Resnicoff, M., Abraham, D., Yutanawiboonchai, W., Rotman, H. L., Kajstura, J., Rubin, R., Zoltick, P., and Baserga, R., The insulin-link growth factor I receptor protects tumor cells from apoptosis in vivo. Cancer Res., 55: 2463-2469, 1995.
12. Turner, B. C., Haffty, B. G., Narayanan, L., Yuan, J., Havre, P. A., Gumbs, L. K., Burgaud, J-L., Carter, D., Baserga, R., and Glaazer, P. M. Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation. Cancer Res., 57: 3079-3083, 1997.
13. Krzystof, R., D'Ambrosio, C., Tu, X., Tu, C., and Baserga, R. Inhibition of tumor growth by a dominant negative mutant of the insulin-link growth factor I receptor with a bystander effect. Clin. Cancer Res., 4: 2647-2655, 1998.
14. Burow, S., Andrulis, I., Pollak, M., and Bell, R. S. Expression of insulin-like growth factor receptor, IGF-1, and IGF-2 in primary and metastatic osteosarcoma. J. Surg. Oncol., 69: 21-27, 1998.
15. Sekyi-Out, A., Bell, R. S., Ohashi, C., Pollak, M., and Andrulis, I. L. Insulin-like growth factor 1 (IGF-1) receptors, IGF-1, and IGF-2 are expressed in primary human sarcomas. Cancer Res., 55: 129-134, 1995.
16. Kanter-Lewensohn, L., Dricu, A., Wang, M., Wejde, J., Kiessling, R., and Larsson, O. Expression of the insulin-like growth factor-1 receptor and its anti-apoptotic effect in malignant melanoma: a potential therapeutic target. Melanoma Res., 8: 389-397, 1998.
17. Noonan, K. E., Beck, C., Holzmayer, T. A., Chin, J. E., Wunder, J. S., Andrulis, I. L., Gazdar, A. F., Willman, C. L., Griffith, B., Von Hoff, D. D., and Roninson, I. B. Quantitative analysis of MDR1 (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc. Natl. Acad. Sci. USA, 87: 7160-7164, 1990.
18. Dricu, A., Carlberg, M., Wang, M., and Larsson, O. Inhibition of N-linked glycosylation using tunicamycin causes cell death in human malignant cells: role of down-regulation of the insulin-like growth factor-1 receptor in induction of apoptosis. Cancer Res., 57: 543-548, 1997.
19. Skytting, B., Bauer, H. C., Perfekt, R., Nilsson, G., and Larsson, O. Ki-67 is strongly prognostic in synovial sarcoma. Analysis based on 86 patients from the Scandinavian Sarcoma Group Register. Br. J. Cancer, in press, 1999.
20. Scotlandi, K., Benini, S., Sarti, M., Serra, M., Lolloni, P-L., Maurici, D., Picci, P., Manara, M. C., and Baldini, N. Insulin-like growth factor I receptor-mediated circuit Ewing's sarcoma/peripheral neuroectodermal tumor: a possible therapeutic target. Cancer Res., 56: 4570-4574, 1996.
21. Long, L., Rubin, R., Baserga, R., and Brodt, P. Loss of the metastatic phenotype in murine carcinoma cells expressing an antisense RNA to the insulin-like growth factor receptor. Cancer Res., 55: 1006-1009, 1995.
22. Long, L., Rubin, R., and Brodt, P. Enhanced invasion and colonization by lung carcinoma cells overexpressing the type 1 insulin-like growth factor receptor. Exp. Cell Res., 238: 116-121, 1998.
23. Burfeind, P., Chernicky, C. L., Rininsland, F., Ilan, J., and Ilan, J. Antisense RNA to the type 1 insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo. Proc. Natl. Acad. Sci. USA, 93: 7263-7268, 1996.
24. Dunn, S. E., Ehrlich, M., Sharp, J. H., Reiss, K., Solomon, G., Hawkins, R., Baserga, R., and Barrett, J. C. A dominant negative mutant of the insulin-like growth factor-I receptor inhibits the adhesion, invasion, and metastasis of breast cancer. Cancer Res., 58: 3353-3361, 1998.